Skip to content

Effects of Autologus Platelet- Rich Plasma on ICSI outcomes and Pregnancy Rate in frozen embryo transfer cycles in Repeated Implantation Failure Patients

Effects of Autologus Platelet- Rich Plasma on ICSI outcomes and Pregnancy Rate in frozen embryo transfer cycles in Repeated Implantation Failure Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017073034422N2
Enrollment
60
Registered
2017-10-16
Start date
2017-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, recurrent implantation failure. Complication associated with artificial fertilization, unspecified

Interventions

Sponsors

Avicenna Research Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 41 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient who has at least 2 cycle IVF failure; At least 6 good quality embryos were transferred in previous cycles; Semen count=10 millions,normal morphology =3% in semen analysis Exclusion criteria: 1-patient without immunologic disorders (abnormality in CD markers, Anti TG, Anti TPO, ds DNA, ANA); hematologic disorder; genetic diseases; uterus disorders; Hb<11 mg/dl and Platelet<150000/mm3; use of corticosteroid during 14 days before of PRP

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chemical pregnancy rate. Timepoint: Two weeks after intervention. Method of measurement: Beta HCG in blood.

Secondary

MeasureTime frame
Implantation Rate. Timepoint: Six weeks after intervention. Method of measurement: Calculation (number of embryos transfer /number of pregnancy sacs in sonography 6 weeks after ET).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSheyda Jouhari

Avicenna Infertility Clinic

s.jouhari@ari.ir info@avic.ir+98 21 23519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026